Search results
Results from the WOW.Com Content Network
While these factors can’t be ruled out, the consistency of the relationship between COVID-19 vaccines and lupus flares indicates that some low percentage of patients will experience an increase ...
DIC may cause a range of symptoms, including abnormal bleeding, breathlessness, chest pain, neurological symptoms, low blood pressure, or swelling. [28] COVID‑19 vaccines have some adverse effects that are listed as common in the two or three days following vaccination which are usually mild and temporary. [21]
A study conducted on 44 rats injected with the Pfizer–BioNTech COVID-19 vaccine at doses over 300 times the human dose by body weight and 44 rats injected with placebo found no statistically significant evidence of any adverse effects on the fertility of female rats or on the health of the offspring of rats (the 3% lower pregnancy rate found ...
Turbo cancer is an anti-vaccination conspiracy theory [1] alleging that people vaccinated against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers.
Significantly more people first developed tinnitus after the first dose of the vaccine, compared with the second. This suggests "that the vaccine is interacting with pre-existing risk factors for ...
It is a viral vector vaccine based on a human adenovirus that has been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus that causes COVID‑19. [5] The body's immune system responds to this spike protein to produce antibodies. [29] The vaccine requires only one dose and does not need to be stored frozen. [30] [31]
Lupus is a chronic disease that can cause inflammation and pain in any part of the body. The disease impacts about 1.5 million Americans, but women are nine times more likely to develop lupus than ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.